A clinical case of atopic dermatitis with a rapid positive effect from the use of a genetically engineered biological drug in a teenager
Introduction. The instructions for the drug dupilumab indicate that the administration of a single loading dose on the first day leads to the rapid achievement of clinically effective concentrations within 2 weeks, which we saw in the example of our patient and her real clinical response to the firs...
Saved in:
| Main Authors: | E. V. Churyukina, E. A. Portnyaga |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Association of Paediatric Allergists and Immunologists of Russia (APAIR)
2024-05-01
|
| Series: | Аллергология и Иммунология в Педиатрии |
| Subjects: | |
| Online Access: | https://adair.elpub.ru/jour/article/view/128 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High Prevalence of Lash Collarettes in Patients with Atopic Dermatitis Treated with Dupilumab
by: Ilaria Trave, et al.
Published: (2025-08-01) -
Dupilumab for the treatment of atopic dermatitis and alopecia areata with incidental improvement of trachyonychia
by: Dana H. Chung, BA, et al.
Published: (2025-09-01) -
The Effect of Dupilumab on Growth Parameters in Pediatric Atopic Dermatitis Patients
by: Vincenzo Piccolo, et al.
Published: (2025-07-01) -
Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis
by: Paulina Stepinska, et al.
Published: (2025-12-01) -
Successful Dupilumab Administration in Adolescent with Alopecia Areata and Atopic Dermatitis: Clinical Case
by: Eduard T. Ambarchyan, et al.
Published: (2024-09-01)